Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2002 Feb;109(2):347.
doi: 10.1542/peds.109.2.347-a.

Continuous subcutaneous glucose monitoring in children with type 1 diabetes

Amnon Zung, Zvi Zadik
Comment

Continuous subcutaneous glucose monitoring in children with type 1 diabetes

Amnon Zung et al. Pediatrics. 2002 Feb.

Abstract

Objective: To examine the feasibility of daily use of a continuous glucose monitor, the FreeStyle Navigator™ Continuous Glucose Monitoring System (“Navigator”), in children with type 1 diabetes (T1D).

Research Design and Methods: Following use of a masked Navigator for 4 to 7 days to establish a baseline level of glycemic control, 30 insulin pump users with T1D (average age 11.2 years) were asked to use the Navigator daily for 13 weeks.

Results: Subjects averaged 149 hours/week of Navigator use during the first 4 weeks, which decreased slightly to 134 hours/week during weeks 9 to 13 (P=0.006). Mean hemoglobin A1c improved from 7.1% at baseline to 6.8% at 13 weeks (P=0.02) and the percentage of glucose values between 71 and 180 mg/dL increased from 52% to 60% (P=0.01). Subjects and parents reported high satisfaction with the Navigator on the Continuous Glucose Monitor Satisfaction Scale. Two subjects had severe skin reactions related to sensor mount adhesive.

Conclusion: This study indicates that incorporating real-time continuous glucose monitoring into the daily management of T1D in children is feasible. The results provide a compelling rationale for conducting a randomized trial of daily use of a continuous glucose monitor in children with T1D.

PubMed Disclaimer

Figures

Figure 1
Figure 1
See this image and copyright information in PMC

Comment on

References

    1. Diabetes Research in Children Network (DirecNet) Study Group. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care. 2005;28:1101–1106. - PubMed
    1. Diabetes Research in Children Network (DirecNet) Study Group. The accuracy of the Freestyle Navigator™ Continuous Glucose Monitoring System in children with type 1 diabetes. Diabetes Care. 2006 In Press. - PubMed
    1. Draize JH, Woodward G, Calvary HO. Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther. 1944;82:377–390.
    1. Diabetes Research in Children Network (DirecNet) Study Group. Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes. 2005;6:13–16. - PubMed
    1. Varni JW, Burwinkle TM, Jacobs JR, Gottschalk M, Kaufman F, Jones KL. The PedsQL™ in Type 1 and Type 2 diabetes: reliability and validity of the Pediatric Quality of Life Inventory™ Generic Core Scales and Type 1 Diabetes Module. Diabetes Care. 2003;26:631–637. - PubMed

MeSH terms